IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q3 2014 Holdings

Filed 2014-11-14 | 4 holdings | $97.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Synta Pharmaceuticals CorpCOM87162T206$90.9K30,194,89893.6%
Celator Pharmaceuticals IncCOM15089R102$5.7K2,246,4695.9%
Covidien PLCSHSG2554F113$3794,3810.4%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$20027,4150.2%